Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-Reply
- PMID: 31790532
- DOI: 10.1001/jamainternmed.2019.5078
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-Reply
Erratum in
-
Language Errors in Text.JAMA Intern Med. 2020 Feb 1;180(2):338. doi: 10.1001/jamainternmed.2019.6864. JAMA Intern Med. 2020. PMID: 31860003 Free PMC article. No abstract available.
Comment on
-
Preclinical Alzheimer Disease-Early Diagnosis or Overdiagnosis?JAMA Intern Med. 2019 Sep 1;179(9):1161-1162. doi: 10.1001/jamainternmed.2019.2629. JAMA Intern Med. 2019. PMID: 31282928 No abstract available.
-
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease.JAMA Intern Med. 2019 Dec 1;179(12):1736-1737. doi: 10.1001/jamainternmed.2019.5114. JAMA Intern Med. 2019. PMID: 31790526 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
